Skip to content

A Randomized Clinical trial on optimized electroacupuncture therapy for stress urinary incontinence in community women

A Randomized Clinical trial on optimized electroacupuncture therapy for stress urinary incontinence in community women

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400084460
Enrollment
Unknown
Registered
2024-05-16
Start date
2024-05-16
Completion date
Unknown
Last updated
2024-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stress Urinary Incontinence

Interventions

Waiting for treatment group:Lifestyle adjustment

Sponsors

South Branch of Guang'anmen Hospital, Chinese Academy of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Subject has involuntary leakage of urine on effort, exertion, sneezing or coughing that stops when the stress ends;has no symptoms of urinary frequency and urgency. 2.Subject is 20–75 years old; 3.Subject with a pad weight gain >1g and <10g in a 1-h pad test; 4.Subject with pattern of spleen deficiency or kidney deficiency with failure in control; 5.Subject voluntarily joins the research and signs the informed consent.

Exclusion criteria

Exclusion criteria: 1.Subject has urge urinary incontinence, mixed urinary incontinence, or overflow urinary incontinence; 2.Subject has symptomatic urinary tract infection; 3.Subject has urinary or pelvic system tumors; 4.Subject has female genital prolapse greater than degree 2; 5.Subject has residual urinary volume (RUV) >30 mL; 6. Subject has maximum flow rate (Qmax) =20 mL/s; 7.Subject is receiving other treatment for SUI, or taking medicine that may affect bladder function; 8.Subject has had an operation for urinary incontinence or on the pelvic floor; 9.Subject has uncontrolled diabetes or hypertension; 10.Subject has multiple system atrophy, dementia, Parkinson's disease, spinal cord injury ,injury of cauda equina, or myeleterosis ; 11.Subject has serious cardiovascular, cerebral, liver, kidney, or psychiatric diseases, coagulation disorders; 12.Subject has a cardiac pacemaker implanted; 13.Subject is limited in walking, stair climbing, or running; 14.Subject has a metal allergy, or a severe needle phobia; 15.Subject during pregnancy.

Design outcomes

Primary

MeasureTime frame
The amount of urine leakage, measured by the 1-hour pad test;

Secondary

MeasureTime frame
Change from baseline in mean 24-h incontinence episodes;Proportions of patients with at least 50% decrease from baseline in the mean 24-hour urinary incontinence episodes;Change from baseline in ICIQ-SF score ;

Countries

China

Contacts

Public ContactFengwei

Huangcun Hospital of Daxing District, Beijing

453457177@qq.com+86 189 1027 7637

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026